Most Recent
The state of Queensland is facing two class actions for allegedly failing to place First Nations children who were removed from their families with other community members and to ensure they maintained a connection to their family, community and culture.
Wealth manager E&P Financial Group has agreed to a $16 million settlement in a class action by Dixon Advisory clients who allege they suffered financial loss when the firm and its directors encouraged the purchase of high risk securities.
A judge has upheld a ruling that rejected a bid by two class actions against Victorian aged care providers for insurance and financial information, finding the court likely does not have the power to order the production of documents that are not relevant to the proceeding.
A judge has granted a bid for a new mediator in a class action over allegedly combustible cladding, agreeing with the applicant that a "fresh start" may be beneficial.
AMP has been taken to court by a former licenced financial advisor who alleges he was terminated without proper and sufficient cause and forced to sell his business for $6.1 million under the wealth manager's buyer of last resort program.
The receivers of Sydney fraudster Melissa Caddick's estate have reached an agreement with her husband on a small pool of remaining assets in dispute that will see half of her teenaged son's sneaker collection sold to repay defrauded investors.
A leading class action firm may seek compensation for those who were illegally detained after the High Court ruled that Australia's system of holding individuals indefinitely in immigration detention is unlawful.
The High Court has declined to weigh in on a dispute between a retired law firm partner and the ATO over tax on $182,000 in goodwill payments the lawyer received upon exiting the firm's partnership.
South Korean biosimilars company Samsung Bioepis has sued to invalidate two patents held by a German competitor for a pre-filled syringe to treat age-related eye diseases, as generic drug makers race for a piece of the lucrative eye drug market.
The Indian government has lodged an appeal after a judge found it can't avoid a $111.3 million arbitral award in a dispute with three Mauritian companies that invested in Indian satellites.